Organization
Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center
1 abstract
Abstract
Initial results from a first in human dose escalation trial of a novel immune stimulating oncolytic adenovirus, AdAPT-001TGF-ß Trap.Org: University of Texas MD Anderson Cancer Center, The Cleveland Clinic Foundation, City of Hope National Medical Center, EpicentRx, Mary Crowley Cancer Research Center,